title: Antibody to the nonstructural protein NS1 of Japanese encephalitis virus: potential application of mAb-based indirect ELISA to differentiate infection from vaccination.
abstract: An indirect enzyme-linked immunosorbent assay (ELISA) was developed to detect and differentiate the antibody responses to Japanese encephalitis (JE) virus nonstructural protein NS1 between infected and vaccinated individuals. The results showed that all convalescent sera from JE patients contained NS1-specific IgG antibodies, while 65 and 40% of these sera showed detectable NS1-specific IgM and IgA antibodies, respectively. Specificity analysis showed that NS1-specific IgM and IgA antibodies from JE patients do not cross-react to dengue virus NS1 glycoprotein, while IgG antibodies from 10% of JE patients showed significant cross-reaction to dengue virus NS1 glycoprotein. To differentiate infection from vaccination, the immune sera from 24 children vaccinated with inactivated JE vaccine were analyzed. The data showed that none of these immune sera had detectable NS1-specific IgG antibodies. The results demonstrated the potential application of JE NS1-specific indirect ELISA to differentiate infection from vaccination.
authors.affiliation: Division of Vector-borne Infectious Diseases, Center for Disease Control, Department of Health, 161 Kun-Yang Street, Taipei, Taiwan, PR China.
authors.forename: P Y
authors.initials: PY
authors.lastname: Shu
authors.forename: L K
authors.initials: LK
authors.lastname: Chen
authors.forename: S F
authors.initials: SF
authors.lastname: Chang
authors.forename: Y Y
authors.initials: YY
authors.lastname: Yueh
authors.forename: L
authors.initials: L
authors.lastname: Chow
authors.forename: L J
authors.initials: LJ
authors.lastname: Chien
authors.forename: C
authors.initials: C
authors.lastname: Chin
authors.forename: T H
authors.initials: TH
authors.lastname: Lin
authors.forename: J H
authors.initials: JH
authors.lastname: Huang
mesh_terms: D000328:Adult; D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology* / Q000302:isolation & purification; D000914:Antibodies, Viral / Q000276:immunology*; D000918:Antibody Specificity / Q000276:immunology; D002648:Child; D002522:Chlorocebus aethiops; D003289:Convalescence; D003429:Cross Reactions / Q000276:immunology; D003715:Dengue / Q000276:immunology; D003716:Dengue Virus / Q000737:chemistry / Q000276:immunology; D004664:Encephalitis Virus, Japanese / Q000737:chemistry / Q000276:immunology*; D004672:Encephalitis, Japanese / Q000276:immunology* / Q000821:virology*; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods*; D006801:Humans; D007106:Immune Sera / Q000276:immunology; D007070:Immunoglobulin A / Q000276:immunology; D007074:Immunoglobulin G / Q000276:immunology; D007075:Immunoglobulin M / Q000276:immunology; D009500:Neutralization Tests; D012680:Sensitivity and Specificity; D014611:Vaccination; D014709:Vero Cells; D017361:Viral Nonstructural Proteins / Q000276:immunology*; D014765:Viral Vaccines / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D000914:Antibodies, Viral; D007106:Immune Sera; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; C100315:NS1 protein, Flavivirus; D017361:Viral Nonstructural Proteins; D014765:Viral Vaccines